Glenmark Pharmaceuticals has received final approval from the US health regulator for Pimecrolimus Cream, used to treat skin conditions such as eczema. The approved product...
Continue ReadingThe approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 percent, of Bausch & Lomb. Drug firm Alembic Pharmaceuticals...
Continue ReadingThe U.S. Food and Drug Administration (FDA) has approved a new treatment option for patients with advanced esophageal cancer — the immunotherapy drug pembrolizumab, known...
Continue ReadingDSV has announced that its acquisition of Panalpina will finally be completed in a deal worth $5.5bn. The combined company will be recognised as DSV...
Continue ReadingBiocon Ltd’s Malaysian subsidiary has received the Certificate of Good Manufacturing Practice (cGMP) compliance from the European drug regulator for its integrated insulin facility, helping...
Continue ReadingNovartis has received European approval for Kymriah, its gene-modifying therapy for blood cancer, but said its introduction would vary from country to country as the...
Continue ReadingThe approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 percent, of Bausch & Lomb. Drug firm Alembic Pharmaceuticals...
Continue ReadingThe pharmaceutical supply chain situation in India is extremely complex due to the complex supply chain environment along with the presence of more than 55,000...
Continue ReadingNovartis, which last week was publicly shamed by the FDA for manipulating data tied to the application of its gene therapy Zolgensma, has said that...
Continue Reading